Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Press Release

Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for Commercializing the specialty product FIBROMUN

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

SunPharma on Twitter

Words matter. By using mental health terms mindfully, we can foster a more compassionate and supportive environment for everyone. This #WorldMentalHealthDay, let’s commit to speaking more thoughtfully.

Mental health is an essential aspect of our overall well-being and affects how we think, feel, and act.

According to @WHO, 1 in every 8 people in the world, live with a mental disorder, highlighting the need for greater awareness and support.

Let's foster an environment that…

We are excited to showcase our extensive API portfolio, catering to both large generic and innovator companies, at CPHI 2024. With backward integration and 13 manufacturing facilities adhering to multiple international GMP standards, we ensure supply reliability.

Visit our booth…

We have entered into a global licensing agreement with Philogen for commercialising their innovative anti-cancer immunotherapy specialty product, Fibromun.

Read more here: https://bit.ly/3Y4Iwqn

At Sun, sustainability is at the core of who we are. We're proud to be ranked 19th among India’s Top 50 Most Sustainable Companies and 3rd in the ‘Pharma & Healthcare’ sector at @BWBusinessworld's 6th Sustainable World Conclave 2024.

This recognition reaffirms our commitment to…

Recent studies highlight a concerning rise in heart issues among young adults aged 25-49 globally. This World Heart Day, prioritize your well-being with a #HeartToHeartCheck.

Source: Wu P et al, Front Cardiovasc Med. 2023 Nov 24;10:1274663

#WorldHeartDay #WorldHeartDay2024

Big ideas deserve big support! To empower young researchers in India, the Sun Pharma Science Foundation invites applications for its Clinical Research Fellowship 2024.
Selected candidates will have the opportunity to conduct independent clinical research, enabling them to drive…

Load More

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top